Source: International Congress 2019 – Advances in bronchiectasis and non-TB mycobacterial infections
Disease area: Airway diseases, Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
S. Aliberti (Milan, Italy), R. Menendez (Valencia, Spain), F. Blasi (Milano, Italy), F. Ringshausen (Hannover, Germany), A. De Soyza (Newcastle upon Tyne, United Kingdom), M. Vendrell (Girona, Spain), P. Goeminne (Leuven, Belgium), E. Polverino ( Barcelona, Spain), W. Boersma ( Alkmaar, Netherlands), C. Haworth ( Cambridge, United Kingdom), M. Murris ( Toulouse, France), K. Dimakou (Athens, Greece), A. Hill ( Edinburgh, United Kingdom), M. Loebinger (London, United Kingdom), A. Torres (Barcelona, Spain), T. Welte (Hannover, Germany), R. Wilson (London, United Kingdom), S. Elborn (London, United Kingdom), J. Chalmers (Dundee, United Kingdom). Determinants of survival in the European Bronchiectasis Registry(EMBARC). 4949

Member's Comments

No comment yet.

Related content which might interest you: European Trends in Chronic Obstructive Pulmonary Disease Mortality and Incidence rates 2001 to 2017 Source: Virtual Congress 2020 – Prevalence and incidence of chronic lung diseases Year: 2020 Viral prevalence in stable bronchiectasis: analysis of the Cohort of Asian and Matched European Bronchiectasis (CAMEB) Source: International Congress 2019 – Phenotypes and endotypes of bronchiectasis Year: 2019 Asthma as a co-morbidity and cause of bronchiectasis: data from the European Bronchiectasis Registry (EMBARC). Source: Virtual Congress 2020 – Non-tuberculous mycobacterial infections and bronchiectasis Year: 2020 Estimating Chronic Respiratory Disease (Asthma and COPD) burden in adults in Asian LMICs: a pilot study for 4CCORD [4 Country ChrOnic Respiratory Disease study]. Source: Virtual Congress 2020 – Exhaled biomarkers of asthma and the asthma burden Year: 2020 The European Bronchiectasis Guidelines  Source: International Congress 2017 – Bronchiectasis: from guidelines to real life Year: 2017 Difficult to manage COPD Exacerbations: Risk factors (DIMECO Study). Turkish Thoracic Society COPD Assembly. Source: Virtual Congress 2020 – Prediction and management of outcomes in obstructive diseases Year: 2020 Impact of treatment strategy in survival of patients with idiopathic pulmonary arterial hypertension. Real world evidence from Spanish National Pulmonary Hypertension Registry (REHAP) Source: International Congress 2018 – Pulmonary hypertension: therapy Year: 2018 Post-Tuberculosis Bronchiectasis in India:Outcomes of the Indian EMBARC Registry Source: International Congress 2018 – Pulmonary tuberculosis: long term complications, rehabilitation and challenges Year: 2018 Long term clinical outcomes of bronchiectasis in India: Data from the EMBARC/RRNI Indian Bronchiectasis Registry Source: Virtual Congress 2021 – Respiratory infections and bronchiectasis outcomes Year: 2021 The European Network For Understanding Mechanisms Of Severe Asthma study Source: Eur Respir J 2004; 23: 492 Year: 2004 Cross-infection risk in patients with bronchiectasis: a position statement from the European Bronchiectasis Network (EMBARC), EMBARC/ELF patient advisory group and European Reference Network (ERN-Lung) Bronchiectasis Network Source: Eur Respir J, 51 (1) 1701937; 10.1183/13993003.01937-2017 Year: 2018 Management of bronchiectasis in Europe: Data from the European bronchiectasis registry (EMBARC) Source: International Congress 2016 – Clinical update on bronchiectasis Year: 2016 Lung function decline and outcomes in an elderly population: findings from the Cardiovascular Health Study Source: Eur Respir J 2005; 26: Suppl. 49, 518s Year: 2005 Late Breaking Abstract - Characteristics of T2-biomarker low severe asthma patients in the UK Severe Asthma Registry (UKSAR) Source: International Congress 2019 – Asthma epidemiology in the 21st century Year: 2019 Heterogeneity in bronchiectasis service provision in Europe: Baseline data from the European bronchiectasis registry (EMBARC) Source: International Congress 2015 – Bronchiectasis and NTM infections: clinical aspects and research outlook Year: 2015 Late Breaking Abstract - Thoracic Cancers International COVID-19 Collaboration (TERAVOLT): Impact of type of cancer therapy and COVID therapy on survival. Source: Virtual Congress 2020 – COVID-19 clinical studies Year: 2020 Applying the ESPEN definition of Malnutrition in patients with stable Chronic Pulmonary Obstructive Disease: associations with Mortality and Healthcare use at 2 years Source: International Congress 2018 – Aspects of pulmonary rehabilitation and chronic care Year: 2018 The German Severe Asthma Registry: Obesity is associated with asthma parameters Source: Virtual Congress 2020 – Phenotypes of asthma and COPD Year: 2020 Comparison of Eosinophilic and Non-eosinophilic Cases with Chronic Obstructive Pulmonary Disease (COPD) in terms of Clinical Arrival, Exacerbations, Quality of Life and Response to Treatment: A Prospective Study Source: International Congress 2019 – Airway diseases and blood cells Year: 2019 Cross-sectional analysis of the Belgian severe asthma registry (BSAR) Source: International Congress 2014 – Direct and indirect monitoring of comorbidities Year: 2014